Cell-of-origin and bone marrow involvement increase specificity of defining patients with diffuse large B-cell lymphoma at high risk of CNS relapse: a study of 793 patients treated with chemoimmunotherapy in Asia.

Ong, Shin Yeu; Phipps, Colin; Nagarajan, Chandramouli; Tang, Tiffany; Lim, Soon Thye; Goh, Yeow Tee; Lee, Yuh Shan

Ong, Shin Yeu; Phipps, Colin; Nagarajan, Chandramouli; Tang, Tiffany; Lim, Soon Thye; Goh, Yeow Tee; Lee, Yuh Shan.

Affiliation

Ong SY; Department of Haematology, Singapore General Hospital, Singapore.
Phipps C; Parkway Cancer Centre, Singapore.
Nagarajan C; Department of Haematology, Singapore General Hospital, Singapore.
Tang T; National Cancer Center, Singapore.
Lim ST; National Cancer Center, Singapore.
Goh YT; Department of Haematology, Singapore General Hospital, Singapore.
Lee YS; Parkway Cancer Centre, Singapore.

Leuk Lymphoma ; 61(1): 225-227, 2020 01.

Article in En | MEDLINE | ID: mdl-31379229

Subject(s)

Central Nervous System Neoplasms; Lymphoma, Large B-Cell, Diffuse; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Asia; Bone Marrow; Humans; Lymphoma, Large B-Cell, Diffuse/drug therapy; Neoplasm Recurrence, Local

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse / Central Nervous System Neoplasms Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2020 Type: Article Affiliation country: Singapore

Fulltext

XML

PubMed Links

Search on Google